Cases & Deals

King Pharmaceuticals faces Item Development AB in patent interference involving myocardial dysfunction

Clients King Pharmaceuticals Research & Development, Inc.

Jones Day provided representation to King Pharmaceuticals, Inc. in a patent interference against Item Development AB before the U.S. Patent and Trademark Office involving methods for detecting the presence and assessing the severity of myocardial dysfunction.

King Pharmaceuticals Research & Development, Inc. v. Item Development AB, Interference No. 105,620

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.